Predictors of Renal Failure in Patients Treated With the Total Artificial Heart

Kevin V Desai1, Daniel G Tang2, Mohammed Quader1

  • 1The Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia.

Insights

High rates of hemodialysis after total artificial heart implantation are linked to increased mortality. Predictors include lower kidney function, coronary artery disease, and need for preoperative oxygenation support.

Area of Science:

  • Cardiovascular Surgery
  • Nephrology
  • Critical Care Medicine

Background:

  • High incidence of hemodialysis-dependent renal failure post-total artificial heart (TAH) implantation.
  • Need to identify preoperative factors predicting hemodialysis requirement after TAH.

Purpose of the Study:

  • To determine preoperative predictors of hemodialysis after TAH implantation.
  • To assess the association between hemodialysis and mortality risk post-TAH.

Main Methods:

  • Retrospective study of 87 patients undergoing TAH implantation (April 2006 - March 2017).
  • Logistic regression analysis to identify predictors of postimplantation hemodialysis.
  • Follow-up until death or heart transplantation.

Main Results:

  • 28% of patients required postimplantation hemodialysis.
  • Predictors for hemodialysis included coronary artery disease history (58% vs 29%), preoperative membrane oxygenation (33% vs 4.8%), and lower estimated glomerular filtration rates (eGFR).
  • Patients requiring hemodialysis had a significantly higher risk of 1-year mortality (33% vs 5%).

Conclusions:

  • Postimplantation hemodialysis is common after TAH and associated with increased mortality.
  • Lower baseline eGFR, coronary artery disease, and preoperative membrane oxygenation are key predictors of hemodialysis need.
  • Identifying at-risk patients can guide management and improve outcomes after TAH implantation.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
801
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
726
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
205
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
174
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
351
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
608